TLtablelabs
All protocols
Tirzepatide vial
TL-002Tirzepatide30mg
TL-002Weight Management

Tirzepatide

Dual GIP and GLP-1 agonist studied for body-weight and blood-glucose outcomes.

Vial strength

Order from the shop →

How it works

Activates both GIP and GLP-1 receptors, a pairing examined for its effects on insulin secretion and satiety.

Research areas

  • Glycaemic control
  • Satiety signalling
  • Body composition

Format

Lyophilised powder, single vial · 30mg

Storage

Store sealed vials at 2–8 °C away from light. Once reconstituted, keep refrigerated and use within the window stated on the batch certificate.

Reconstitution

  1. Let the sealed vial reach room temperature before opening.
  2. Wipe the stopper with an alcohol swab and use sterile technique throughout.
  3. Add the diluent volume listed on the batch certificate slowly down the inside wall of the vial.
  4. Swirl gently until clear — do not shake. Label with date and concentration.

For laboratory research only. This sheet is a general handling reference, not medical advice. It is not intended for human or veterinary use.